Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons

20260 citationsJournal Articlegold Open Access

Authors

Holger N. Lode · Universitätsmedizin Greifswald

Przemysław Holko · Jagiellonian University

Aleksandra Wieczorek · Jagiellonian University

Katarzyna Śladowska · Jagiellonian University

Nikolai Siebert · Universitätsmedizin Greifswald

Dominique Valteau-Couanet · Université Paris-Sud

Alberto Garaventa

Abstract

Dinutuximab beta significantly prolonged OS compared to historical control cohorts not treated with dB in both unadjusted and adjusted indirect comparisons.

Topics & Keywords

Neuroblastoma Research and Treatments Cancer, Hypoxia, and Metabolism Virus-based gene therapy research

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Frontiers in Oncology

Volume 15, pp. 1736165-1736165

DOI: 10.3389/fonc.2025.1736165

Field-Weighted Citation Impact: 0.00